Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
4 clinical trials · Sponsor
◉ Watch Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
| Record | Firm | Date |
|---|---|---|
| Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults (NCT02610868) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2015-10-01 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects (NCT01994109) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2013-11-01 |
| A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients (NCT00515437) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2007-07-01 |
| Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia (NCT00702754) | Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC | 2001-06-01 |
Track Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC automatically
Every clearance here is in the API, with alerts when new ones post.